Furthermore, an increased expression of miR-148a has been observed in GBM glioma cell lines, which targets and diminishes the expression of QKI, leading to the augmented and sustained activation of NF-κB and TGF-β/Smad signaling pathways, which in turn inhibits cell proliferation, migration, and invasion. This evidence concerns the gene QKI and central nervous system cancer.